Clinical trials in DeSoto, TX

28 recruiting studies have a site in or near DeSoto, TX, Texas.

Top conditions here

All conditions

Showing 28 of 28 studies

RecruitingPhase 3NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi

Allen, TX · Beaumont, TX · Bellaire, TX · +72 more sites

RecruitingPhase 4NCT07221877

A Study to Evaluate the Effect of KarXT on Urological Safety

Sponsor: Bristol-Myers Squibb

Austin, TX · DeSoto, TX · +14 more sites

RecruitingPhase 3NCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Cypress, TX · DeSoto, TX · El Paso, TX · +145 more sites

RecruitingPhase 2NCT07459647

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Sponsor: MapLight Therapeutics

Austin, TX · DeSoto, TX · Houston, TX · +42 more sites

RecruitingPhase 2NCT07610473

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Sponsor: Draig Therapeutics Ltd

DeSoto, TX · Fort Worth, TX · +21 more sites

RecruitingPhase 3NCT07816367

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Austin, TX · Beaumont, TX · Dallas, TX · +69 more sites

RecruitingNot applicableNCT04101669

The RESET System Pivotal Clinical Trial (Protocol Revision K)

Sponsor: Morphic Medical Inc.

Atascocita, TX · Dallas, TX · DeSoto, TX · +24 more sites

RecruitingPhase 2NCT07300969

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Sponsor: Draig Therapeutics Ltd

Austin, TX · DeSoto, TX · +20 more sites

RecruitingPhase 2NCT07410507

A Study of Brenipatide in Adult Participants With Schizophrenia

Sponsor: Eli Lilly and Company

DeSoto, TX · Fort Worth, TX · +30 more sites

RecruitingPhase 3NCT07775300

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Sponsor: Eli Lilly and Company

Austin, TX · Beaumont, TX · DeSoto, TX · +31 more sites

RecruitingPhase 3NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Sponsor: Amgen

Austin, TX · Bellaire, TX · Dallas, TX · +68 more sites

RecruitingPhase 3NCT07668414

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Sponsor: Novo Nordisk A/S

Amarillo, TX · Austin, TX · Brownsville, TX · +42 more sites

RecruitingPhase 3NCT07761117

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Sponsor: AstraZeneca

Dallas, TX · DeSoto, TX · El Paso, TX · +117 more sites

RecruitingPhase 3NCT07114874

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Sponsor: Neurocrine Biosciences

Austin, TX · DeSoto, TX · Houston, TX · +47 more sites

RecruitingPhase 3NCT07227818

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Sponsor: Neurocrine Biosciences

DeSoto, TX · +21 more sites

RecruitingPhase 3NCT06439277

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Sponsor: Eli Lilly and Company

Corpus Christi, TX · DeSoto, TX · Fort Worth, TX · +11 more sites

RecruitingPhase 3NCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Austin, TX · Dallas, TX · DeSoto, TX · +99 more sites

RecruitingPhase 1 / Phase 2NCT07412704

A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

Sponsor: Bristol-Myers Squibb

DeSoto, TX · +10 more sites

RecruitingPhase 3NCT07784270

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Sponsor: AstraZeneca

DeSoto, TX · El Paso, TX · Houston, TX · +51 more sites

RecruitingPhase 3NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Sponsor: Ascletis Pharma (China) Co., Limited

Austin, TX · Brownsville, TX · DeSoto, TX · +81 more sites

RecruitingPhase 3NCT05125302

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Sponsor: AbbVie

Austin, TX · +122 more sites

RecruitingPhase 3NCT07369154

52-week Open Label Safety-Tolerability Study

Sponsor: LB Pharmaceuticals Inc.

DeSoto, TX · Richardson, TX · +21 more sites

RecruitingPhase 3NCT05303064

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Sponsor: Alkermes, Inc.

DeSoto, TX · Fort Worth, TX · +24 more sites

RecruitingPhase 1NCT05025605

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Sponsor: BioXcel Therapeutics Inc

DeSoto, TX · +4 more sites

RecruitingPhase 3NCT07177339

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Sponsor: GlaxoSmithKline

Dallas, TX · DeSoto, TX · Greenville, TX · +39 more sites

RecruitingPhase not listedNCT05800925

Triage Survey for Psychiatry Research Eligibility

Sponsor: Adams Clinical

DeSoto, TX · +5 more sites

RecruitingPhase 2NCT06524830

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Sponsor: atai Therapeutics, Inc.

Austin, TX · DeSoto, TX · Plano, TX · +31 more sites

RecruitingPhase 3NCT06963034

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Sponsor: Neurocrine Biosciences

Austin, TX · DeSoto, TX · Houston, TX · +18 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.